A
Aurisco Pharmaceutical Co Ltd
SSE:605116
Aurisco Pharmaceutical Co Ltd
SSE:605116
Price:
23.69 CNY
-1.29%
Market Closed
Updated:
May 17, 2024
Aurisco Pharmaceutical Co Ltd
Operating Expenses
|
Aurisco Pharmaceutical Co Ltd
Operating Expenses Peer Comparison
Comparables:
H
3692
600436
600276
000538
S
688506
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
Aurisco Pharmaceutical Co Ltd
SSE:605116
|
Operating Expenses
-¥296.9m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Operating Expenses
-¥6.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Operating Expenses
-¥1.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-17%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Operating Expenses
-¥14.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-15%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Operating Expenses
-¥6.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-12%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Operating Expenses
-¥1.1B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Aurisco Pharmaceutical Co Ltd's Operating Expenses?
Operating Expenses
-296.9m
CNY
-296.9m
CNY
Based on the financial report for Dec 31, 2022, Aurisco Pharmaceutical Co Ltd's Operating Expenses amounts to -296.9m CNY.
What is Aurisco Pharmaceutical Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-11%
-11%
Over the last year, the Operating Expenses growth was -47%. The average annual Operating Expenses growth rates for Aurisco Pharmaceutical Co Ltd have been -31% over the past three years , -11% over the past five years .
You don't have any saved screeners yet
